{"id":"https://openalex.org/W2005448673","doi":"https://doi.org/10.1016/j.ejphar.2007.08.031","title":"Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-\u03b1 and macrophage inflammatory protein-2 production","display_name":"Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-\u03b1 and macrophage inflammatory protein-2 production","alternate_titles":[],"publication_year":2007,"publication_date":"2007-09-05","ids":{"openalex":"https://openalex.org/W2005448673","doi":"https://doi.org/10.1016/j.ejphar.2007.08.031","mag":"2005448673","pmid":"https://pubmed.ncbi.nlm.nih.gov/17888421"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejphar.2007.08.031","doi":"https://doi.org/10.1016/j.ejphar.2007.08.031","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2007.08.031","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005448673"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110724718","display_name":"Kaoru Ishizaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1306287861","display_name":"Mitsubishi Group (Japan)","ror":"https://ror.org/0234cd281","country_code":"JP","type":"company","lineage":["https://openalex.org/I1306287861"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kaoru Ishizaki","raw_affiliation_strings":["Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan. Ishizaki.Kaoru@mh.m-pharma.co.jp","Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan. Ishizaki.Kaoru@mh.m-pharma.co.jp","institution_ids":[]},{"raw_affiliation_string":"Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":["https://openalex.org/I1306287861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019069505","display_name":"Tomomichi Iwaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1306287861","display_name":"Mitsubishi Group (Japan)","ror":"https://ror.org/0234cd281","country_code":"JP","type":"company","lineage":["https://openalex.org/I1306287861"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomomichi Iwaki","raw_affiliation_strings":["Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":["https://openalex.org/I1306287861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076265683","display_name":"Shuji Kinoshita","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuji Kinoshita","raw_affiliation_strings":["Pharmacokinetics Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109116425","display_name":"Mamoru Koyama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mamoru Koyama","raw_affiliation_strings":["Discovery Technology Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Technology Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018240999","display_name":"Atsushi Fukunari","orcid":"https://orcid.org/0009-0001-2909-6726","observed_orcids":["https://orcid.org/0009-0001-2909-6726"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Atsushi Fukunari","raw_affiliation_strings":["Discovery Technology Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Technology Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101612664","display_name":"Hideki Tanaka","orcid":"https://orcid.org/0000-0002-0936-0905","observed_orcids":["https://orcid.org/0000-0002-0936-0905"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideki Tanaka","raw_affiliation_strings":["Discovery Technology Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Technology Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049353308","display_name":"Makoto Tsurufuji","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Makoto Tsurufuji","raw_affiliation_strings":["Discovery Technology Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Technology Laboratory, Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kei Sakata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1306287861","display_name":"Mitsubishi Group (Japan)","ror":"https://ror.org/0234cd281","country_code":"JP","type":"company","lineage":["https://openalex.org/I1306287861"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kei Sakata","raw_affiliation_strings":["Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":["https://openalex.org/I1306287861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008838827","display_name":"Yasuhiro Maeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1306287861","display_name":"Mitsubishi Group (Japan)","ror":"https://ror.org/0234cd281","country_code":"JP","type":"company","lineage":["https://openalex.org/I1306287861"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuhiro Maeda","raw_affiliation_strings":["Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":["https://openalex.org/I1306287861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023491897","display_name":"Teruaki Imada","orcid":"https://orcid.org/0000-0003-2877-7535","observed_orcids":["https://orcid.org/0000-0003-2877-7535"]},"institutions":[{"id":"https://openalex.org/I1306287861","display_name":"Mitsubishi Group (Japan)","ror":"https://ror.org/0234cd281","country_code":"JP","type":"company","lineage":["https://openalex.org/I1306287861"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Teruaki Imada","raw_affiliation_strings":["Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":["https://openalex.org/I1306287861"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012275284","display_name":"Kenji Chiba","orcid":"https://orcid.org/0000-0002-1687-1746","observed_orcids":["https://orcid.org/0000-0002-1687-1746"]},"institutions":[{"id":"https://openalex.org/I1306287861","display_name":"Mitsubishi Group (Japan)","ror":"https://ror.org/0234cd281","country_code":"JP","type":"company","lineage":["https://openalex.org/I1306287861"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Chiba","raw_affiliation_strings":["Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, Yokohama, Japan","institution_ids":["https://openalex.org/I1306287861"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110724718"],"corresponding_institution_ids":["https://openalex.org/I1306287861"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":1.4313,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.75959004,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"578","issue":"1","first_page":"57","last_page":"64"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.8213000297546387,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.8213000297546387,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0737999975681305,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.07259999960660934,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ursodeoxycholic-acid","display_name":"ursodeoxycholic acid","score":1.0},{"id":"https://openalex.org/keywords/concanavalin-a","display_name":"concanavalin A","score":0.8640000224113464},{"id":"https://openalex.org/keywords/liver-injury","display_name":"liver injury","score":0.8949999809265137},{"id":"https://openalex.org/keywords/hepatoprotective-effect","display_name":"hepatoprotection","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9909999966621399},{"id":"https://openalex.org/keywords/mip-2","display_name":"CXCL2","score":0.996999979019165},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8539999723434448},{"id":"https://openalex.org/keywords/neutrophil-infiltration","display_name":"neutrophil infiltration","score":0.8209999799728394},{"id":"https://openalex.org/keywords/myeloperoxidase","display_name":"myeloperoxidase","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cytokine-expression","display_name":"cytokine expression","score":0.7080000042915344},{"id":"https://openalex.org/keywords/hepatocellular-necrosis","display_name":"liver necrosis","score":0.5849999785423279},{"id":"https://openalex.org/keywords/aminotransferases","display_name":"transaminases","score":0.8999999761581421}],"concepts":[{"id":"https://openalex.org/C19869320","wikidata":"https://www.wikidata.org/wiki/Q419277","display_name":"Concanavalin A","level":3,"score":0.8903354406356812},{"id":"https://openalex.org/C2780965833","wikidata":"https://www.wikidata.org/wiki/Q241374","display_name":"Ursodeoxycholic acid","level":2,"score":0.8666400909423828},{"id":"https://openalex.org/C2776637226","wikidata":"https://www.wikidata.org/wiki/Q6658207","display_name":"Liver injury","level":2,"score":0.6488362550735474},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6407737135887146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6237431168556213},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5482228398323059},{"id":"https://openalex.org/C2780841837","wikidata":"https://www.wikidata.org/wiki/Q24741149","display_name":"Interferon gamma","level":3,"score":0.43829044699668884},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.421735554933548},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39736074209213257},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3359031081199646},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3156265914440155},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.160669207572937},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002756","descriptor_name":"Cholagogues and Choleretics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002756","descriptor_name":"Cholagogues and Choleretics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003208","descriptor_name":"Concanavalin A","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014580","descriptor_name":"Ursodeoxycholic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014580","descriptor_name":"Ursodeoxycholic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020556","descriptor_name":"Neutrophil Infiltration","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054426","descriptor_name":"Chemokine CXCL2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejphar.2007.08.031","doi":"https://doi.org/10.1016/j.ejphar.2007.08.031","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2007.08.031","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:17888421","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17888421","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1605194916","https://openalex.org/W1611445504","https://openalex.org/W1928430680","https://openalex.org/W1967627173","https://openalex.org/W1968221120","https://openalex.org/W1975737817","https://openalex.org/W1982039264","https://openalex.org/W1983459355","https://openalex.org/W1995665866","https://openalex.org/W1995666763","https://openalex.org/W1996562542","https://openalex.org/W1997743635","https://openalex.org/W1998442274","https://openalex.org/W2010334438","https://openalex.org/W2012352047","https://openalex.org/W2013127483","https://openalex.org/W2027113170","https://openalex.org/W2027700151","https://openalex.org/W2042311776","https://openalex.org/W2046544649","https://openalex.org/W2052767033","https://openalex.org/W2061072369","https://openalex.org/W2066125745","https://openalex.org/W2068474470","https://openalex.org/W2071394537","https://openalex.org/W2080267315","https://openalex.org/W2091468751","https://openalex.org/W2097139406","https://openalex.org/W2107340757","https://openalex.org/W2110797810","https://openalex.org/W2133889010","https://openalex.org/W2142984184","https://openalex.org/W2161458396","https://openalex.org/W4252569467"],"related_works":["https://openalex.org/W3212571894","https://openalex.org/W3032590572","https://openalex.org/W2028708565","https://openalex.org/W2368359597","https://openalex.org/W3021466464","https://openalex.org/W2056563212","https://openalex.org/W2368069939","https://openalex.org/W7099404342","https://openalex.org/W2378389636","https://openalex.org/W2389731511"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005448673","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
